HIGHLIGHTS
- who: Christine Årdal from the Norwegian Institute of Public Health, Postboks , Nydalen, Oslo have published the research work: Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations, in the Journal: (JOURNAL)
- what: The research focus of the survey respondents is largely small_molecule development, i.e., traditional antibiotics. Based on the results the authors propose the ranges in Table 2 to estimate development costs of antibiotics for SMEs. Regarding targets, both the stakeholder meeting and the survey confirmed that SMEs are focusing their R and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.